Recently Approved Drugs: Durvalumab for patients with stage III Non-Small Cell Lung Cancers (NSCLC)

ASCO Education Podcast

0:00
11:04
10
10

Recently Approved Drugs: Durvalumab for patients with stage III Non-Small Cell Lung Cancers (NSCLC)

ASCO Education Podcast

Rami Manochakian, M.D., a thoracic clinical oncologist at the Mayo Clinic in Florida, presents information on the recently approved drug in oncology, durvalumab for patients with stage III Non-Small Cell Lung Cancers (NSCLC) after the completion of radiation therapy.

Episodes
Date
Duration
Recommended episodes :

Oncology, Etc. - In Conversation with Dr. Quyen Chu

ASCO Education Podcast

Cancer Topics – Beyond Adjuvant Chemotherapy: Precision Oncology in Early-stage NSCLC

ASCO Education Podcast

Oncology, Etc. - From Personal to Politics – A Discussion about COVID and Oncology

ASCO Education Podcast

The podcast ASCO Education Podcast has been added to your home screen.

Rami Manochakian, M.D., a thoracic clinical oncologist at the Mayo Clinic in Florida, presents information on the recently approved drug in oncology, durvalumab for patients with stage III Non-Small Cell Lung Cancers (NSCLC) after the completion of radiation therapy.

Subscribe Install Share
ASCO Education Podcast

Thank you for your subscription

For a better experience, also consider installing the application.

Install